That 5.4cm difference represents meaningful visceral fat reduction that pure GLP-1 agonism did not achieve
Contraindications and cautions include: Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (absolute contraindication) History of pancreatitis (relative contraindication

Safety monitoring for GLP-1 therapy itself includes: Assessment for gastrointestinal adverse effects, which are common but usually transient Monitoring for signs of pancreatitis (severe, persistent abdominal pain) Vigilance for symptoms suggesting thyroid masses (neck lump, difficulty swallowing, persistent hoarseness) Regular review of glycaemic control in diabetic patients Blood pressure and cardiovascular risk factor assessment Monitoring for gallbladder disease (right upper abdominal pain, fever, jaundice) Eye examinations for people with diabetes, particularly those with pre-existing diabetic retinopathy Renal function checks, especially if experiencing severe gastrointestinal symptoms that could lead to dehydration If you have diabetes and take insulin or sulfonylureas, your doctor may reduce these doses when starting GLP-1 therapy to prevent hypoglycaemia

Discontinuation rates due to adverse events were higher in the active treatment groups compared with placebo, particularly at higher doses, though the overall discontinuation rate remained relatively modest
I love stocking up on versatile item Save this video for your next trip to Costco and add these grocery finds to your list to help you on your weight loss journey
Always consult a professional for guidance, ensure all ingredients are pharmaceutical-grade, maintain strict hygiene, and measure accurately